First-trimester Test-VI, Serum Penta Screen (Free Beta HCG, PAPPa, AFP, Inhibin A, PLGF)
Penta Maternal Screen Panel, Serum** Price
The First Trimester Test-VI, also known as the Penta Screen, is a screening test that is usually performed between 11 to 13.6 weeks of pregnancy. The test is a combination of several different markers that are measured in the mother's blood to assess the risk of chromosomal abnormalities and other fetal disorders.
Free beta human chorionic gonadotropin (β-hCG) is a hormone that is produced by the placenta and is measured in the mother's blood. Abnormal levels of β-hCG can indicate an increased risk of chromosomal abnormalities such as Down syndrome. Pregnancy-associated plasma protein A (PAPP-A) is a protein that is produced by the placenta and is measured in the mother's blood. Low levels of PAPP-A can indicate an increased risk of chromosomal abnormalities. Alpha-fetoprotein (AFP) is a protein that is produced by the fetal liver and is measured in the mother's blood. Abnormal levels of AFP can indicate an increased risk of neural tube defects and other fetal disorders. Inhibin A is a hormone that is produced by the placenta and is measured in the mother's blood. Abnormal levels of inhibin A can indicate an increased risk of chromosomal abnormalities. Placental growth factor (PLGF) is a protein that is produced by the placenta and is measured in the mother's blood. Abnormal levels of PLGF can indicate an increased risk of preeclampsia, a serious pregnancy complication. Nuchal translucency (NT) is a measurement of the thickness of a space at the back of the fetal neck, which is measured by ultrasound. The abnormal thickness of the NT can indicate an increased risk of chromosomal abnormalities and other fetal disorders.
The results of the Penta Screen are combined with the mother's age and other factors to calculate a risk score for chromosomal abnormalities such as Down syndrome, trisomy 18, and trisomy 13.
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.